Literature DB >> 26086079

Proteins involved in focal adhesion signaling pathways are differentially regulated in experimental branch retinal vein occlusion.

Lasse Jørgensen Cehofski1, Anders Kruse2, Benedict Kjærgaard3, Allan Stensballe4, Bent Honoré5, Henrik Vorum6.   

Abstract

Branch retinal vein occlusion (BRVO) is a common retinal vascular disease, but global protein changes following the condition remain largely unelucidated. To bring new insights into pathological processes and identify potential therapeutic targets, large-scale retinal protein changes following BRVO were studied by combining a porcine model of experimental BRVO with proteomic analysis by label-free liquid chromatography mass spectrometry. Among a total set of 1974 proteins, 52 significantly upregulated proteins and 10 significantly downregulated proteins were identified in retinas with BRVO after 15 days. Significantly upregulated proteins were involved in signaling pathways of focal adhesion via integrin and blood coagulation. Proteins involved in focal adhesion signaling included collagen α-2 chain, laminin subunit β-2, laminin subunit γ-1, lipocalin-7, nidogen-2, osteopontin, integrin-β, α-actinin-1, isoform 2 of α-actinin-1, talin-2 and filamin C. The identified proteins indicate that BRVO was associated with extracellular matrix remodeling processes. The present study identified focal adhesion signaling and ECM remodeling as important biological mechanisms to evaluate in the search for signaling pathways that promote neovascularisation and macular edema following BRVO.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adhesion; Biological marker; Branch retinal vein occlusion; Extracellular matrix; Integrin; Lipocalin; Mass spectrometry; Myosin 9; Osteopontin; Proteomics; Retina

Mesh:

Substances:

Year:  2015        PMID: 26086079     DOI: 10.1016/j.exer.2015.06.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  The Pig PeptideAtlas: A resource for systems biology in animal production and biomedicine.

Authors:  Marianne O Hesselager; Marius C Codrea; Zhi Sun; Eric W Deutsch; Tue B Bennike; Allan Stensballe; Louise Bundgaard; Robert L Moritz; Emøke Bendixen
Journal:  Proteomics       Date:  2016-02       Impact factor: 3.984

2.  Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Alexander Nørgaard Alsing; Benn Falch Sejergaard; Jonas Ellegaard Nielsen; Anders Schlosser; Grith Lykke Sorensen; Jakob Grauslund; Bent Honoré; Henrik Vorum
Journal:  Molecules       Date:  2022-05-24       Impact factor: 4.927

3.  Gene expression profiling in a mouse model of retinal vein occlusion induced by laser treatment reveals a predominant inflammatory and tissue damage response.

Authors:  Gottfried Martin; David Conrad; Bertan Cakir; Günther Schlunck; Hansjürgen T Agostini
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

Review 4.  A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.

Authors:  Lasse Jørgensen Cehofski; Bent Honoré; Henrik Vorum
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

5.  Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Alexander Nørgård Alsing; Jonas Ellegaard Nielsen; Shona Pedersen; Svend Kirkeby; Bent Honoré; Henrik Vorum
Journal:  Mol Vis       Date:  2018-11-26       Impact factor: 2.367

6.  Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study.

Authors:  Lasse Jørgensen Cehofski; Kentaro Kojima; Nobuhiro Terao; Koji Kitazawa; Sasikala Thineshkumar; Jakob Grauslund; Henrik Vorum; Bent Honoré
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

7.  Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Mads Odgaard Mæng; Benn Falch Sejergaard; Anders Schlosser; Grith Lykke Sorensen; Jakob Grauslund; Bent Honoré; Henrik Vorum
Journal:  Molecules       Date:  2022-09-03       Impact factor: 4.927

8.  Gene expression profile analysis of the rabbit retinal vein occlusion model.

Authors:  Takuma Neo; Makoto Gozawa; Yoshihiro Takamura; Masaru Inatani; Masaya Oki
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

9.  IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Svend Kirkeby; Alexander Nørgård Alsing; Jonas Ellegaard Nielsen; Kentaro Kojima; Bent Honoré; Henrik Vorum
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.